| Name | Title | Contact Details |
|---|---|---|
Shane McNamee |
Chief Medical Information Officer | Profile |
Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.
Mercola.com is a Hoffman Estates, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Pioneer Surgical is a leading innovator in the design and manufacture of spinal and orthopedic implants and instruments.
Washington Health System provides an integrated healthcare system centered around patients and families. They have been dedicated to providing the highest quality care since 1897. With locations throughout Washington and Greene counties in Pennsylvania...
EMSI Acquired Leprechaun is a Fort Worth, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.